4//SEC Filing
ANDRZEJEWSKI STEPHEN J 4
Accession 0001209191-10-013055
CIK 0001047699other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:09 PM ET
Size
6.4 KB
Accession
0001209191-10-013055
Insider Transaction Report
Form 4
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
- Award
Long-Term Performance Unit
2010-02-25+54,900→ 54,900 totalExp: 2011-12-31→ Common Stock (54,900 underlying)
Footnotes (3)
- [F1]The Long-Term Performance Units (One Year Performance Cycle) ("Long Term Performance Units") were awarded under the King Pharmaceuticals, Inc. Incentive Plan (the "Incentive Plan"). Each Long-Term Performance Unit represents a contingent right to receive one share of King Pharmaceuticals, Inc. common stock.
- [F2]The number of Long-Term Performance Units awarded was based on the achievement of certain 2009 annual earnings per share targets established by the Compensation and Human Resources Committee under the Incentive Plan in early 2009.
- [F3]The Long-Term Performance Units vest in full on December 31, 2011, contingent upon the reporting person's continued employment by King Pharmaceuticals, Inc. as of that date.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeother
Related Parties
1- filerCIK 0001321648
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:09 PM ET
- Size
- 6.4 KB